(RCKT) Rocket Pharmaceuticals - Performance -85.5% in 12m
RCKT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-83.48%
#148 in Peer-Group
Rel. Strength
2.14%
#7511 in Stock-Universe
Total Return 12m
-85.47%
#188 in Peer-Group
Total Return 5y
-87.06%
#106 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 25.88 USD |
| 52 Week Low | 2.33 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 62.03 |
| Buy/Sell Signal +-5 | 0.30 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RCKT (-85.5%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RCKT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RCKT
| Total Return (including Dividends) | RCKT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.68% | 3.36% | 5.25% |
| 3 Months | -43.36% | 15.73% | 24.13% |
| 12 Months | -85.47% | -7.02% | 14.15% |
| 5 Years | -87.06% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | RCKT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -64.6% | 4.4% | 81% |
| 3 Months | -67% | 78.8% | 96.9% |
| 12 Months | -98.3% | -85.8% | 44.9% |
| 5 Years | -60.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th49.50 | -3.91% | -5.64% |
| 3 Month | %th5.00 | -51.06% | -54.37% |
| 12 Month | %th7.00 | -84.37% | -87.27% |
| 5 Years | %th47.00 | -82.93% | -93.89% |
FAQs
Does Rocket Pharmaceuticals (RCKT) outperform the market?
No,
over the last 12 months RCKT made -85.47%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months RCKT made -43.36%, while XBI made 15.73%.
Performance Comparison RCKT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RCKT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 12.9% | -5.9% | -82.2% | -100% |
| US NASDAQ 100 | QQQ | 13.1% | -6% | -82.8% | -98% |
| German DAX 40 | DAX | 15.1% | 0.7% | -94.3% | -114% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 13.1% | -3.9% | -85.6% | -105% |
| Hongkong Hang Seng | HSI | 13.3% | -6.7% | -101.6% | -124% |
| India NIFTY 50 | INDA | 14.8% | -4.2% | -82.5% | -85% |
| Brasil Bovespa | EWZ | 10.5% | -9.5% | -107.2% | -96% |
RCKT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.3% | -6.6% | -86.3% | -110% |
| Consumer Discretionary | XLY | 13.4% | -3.9% | -74.5% | -103% |
| Consumer Staples | XLP | 12.6% | -1.3% | -83.8% | -94% |
| Energy | XLE | 12.6% | -7.7% | -78.1% | -85% |
| Financial | XLF | 12.2% | -5.8% | -87.1% | -115% |
| Health Care | XLV | 13.5% | -2.8% | -74.8% | -81% |
| Industrial | XLI | 12.8% | -4.9% | -90% | -111% |
| Materials | XLB | 10.7% | -5% | -86.7% | -91% |
| Real Estate | XLRE | 13% | -1.7% | -81.9% | -98% |
| Technology | XLK | 12.2% | -9.4% | -84.5% | -97% |
| Utilities | XLU | 14% | -2.5% | -85.4% | -108% |
| Aerospace & Defense | XAR | 15% | -7.7% | -100.8% | -135% |
| Biotech | XBI | 11.9% | -4% | -69% | -78% |
| Homebuilder | XHB | 10.4% | -7.7% | -75% | -91% |
| Retail | XRT | 10.4% | -5.7% | -77.9% | -97% |
RCKT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 12% | -9.12% | -73.8% | -78% |
| Natural Gas | UNG | 22.4% | 9.1% | -65.4% | -83% |
| Gold | GLD | 12.7% | 0.5% | -102.8% | -124% |
| Silver | SLV | 11.9% | -7.6% | -99.5% | -103% |
| Copper | CPER | 13.9% | -5.3% | -99.3% | -96% |
RCKT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 14.7% | -1.7% | -78.8% | -83% |
| iShares High Yield Corp. Bond | HYG | 14.1% | -2.3% | -81.1% | -95% |